The Indian government is working towards scientifically integrating traditional Indian medicine with modern medicine, with the Ministry of Ayush operationalizing 12,500 Ayush health and wellness centers across the country by 2023-24 under the National Ayush Mission (NAM).

Several traditional Indian medicines, part of Ayurveda, have been found to be effective in maintaining blood sugar levels in patients with Type 2 diabetes.

Ayurvedic treatment works by controlling blood sugar and limiting the harmful effects of other drugs, unlike modern diabetes drugs which are known for side effects and toxicity.

Turmeric has been used in Ayurveda and traditional Chinese medicine for the treatment of diabetes.

Around 400 medicinal plants have been identified as having potential anti-diabetic properties, with 21 herbal plants found to have prominent anti-hyperglycemic action.

The herbal drug BGR-34, developed by the Council of Scientific and Industrial Research (CSIR), contains active compounds derived from four medicinal herbs: daruharidra, gudmar, methi, and vijayasar.

BGR-34 has been used to manage diabetes and has been shown to reduce sugar levels and address obesity.

Ashwagandha, a traditional Indian herb, has been proven to reduce anxiety, stress, improve muscle strength, and reduce fatigue symptoms in patients with chronic diseases.

A double-blind clinical trial involving 2,000 people living in the UK with long Covid will be conducted to determine the efficacy of Ashwagandha in helping people recover from long Covid.

The London School of Hygiene & Tropical Medicine is working with the All India Institute of Ayurveda to trial a traditional Indian herb treatment, Ashwagandha, for long Covid.

The World Health Organization (WHO) is establishing a new center in India to study traditional medicine, including Indian herbal medicine, and will use modern technologies such as artificial intelligence and big data to study traditional medicine.

The WHO center will provide a reliable evidence base for policy and standards on traditional medicine practices and products.

The Indian government is documenting medicinal herbs of tribal communities across the country, with a pilot project completed in Uttarakhand, resulting in a five-volume book series documenting over 1,400 medicinal plants.

The National Institute of Pharmaceutical Education and Research (NIPER) found three medicinal plants in their area that, when combined, can be a potential cure for malaria.

The Council of Scientific and Industrial Research (CSIR) has developed a herbal formulation called BGR-34, which contains active compounds derived from four medicinal herbs, to manage diabetes.

The Ministry of Ayush has supported 17 Integrated Ayush hospitals in southern states, with six currently operational.

Maharishi Ayurveda Hospital is a NABH-approved Ayurvedic hospital in India with a 30-year legacy, and offers a range of Ayurvedic treatments, including Abhyanga, Shirodhara, and Swedan.

Ayurvedic treatment has reached the global level, and medications based on Ayurveda are being backed by researchers from all over the world.

Ayurveda offers a holistic approach to treating infertility by addressing the root cause of the problem and promoting overall health and well-being.

The Indian government has allocated around $80 million to the Ministry of Health to strengthen the regulatory system for drugs, including creating laboratories for testing new drugs and modernizing existing ones.

The World Health Organization (WHO) has called on drug manufacturers to strengthen quality control of raw materials and the manufacturing process.

The Indian pharmaceutical industry relies heavily on data to drive its operations and is vulnerable to cyber threats, including ransomware and phishing.

The National Cyber Security Policy and the Data Protection Bill in India set high standards for cybersecurity practices to prevent breaches and avoid severe penalties.

The Indian government is planning to revise Schedule M of the Drugs and Cosmetics Rules, 1945, to bring it closer to World Health Organization (WHO) standards.

The revision aims to strengthen quality control and safety of drugs manufactured in India.

The Central Drugs Standard Control Organisation (CDSCO) is the national regulatory authority in India responsible for ensuring the quality, safety, and efficacy of drugs, including herbal medicine products.

The CDSCO has requested the WHO to share a report on the causal relationship between certain syrups and the deaths of children in Gambia.

The Indian government has set new manufacturing standards for pharmaceutical companies in the country to ensure the quality, safety, and efficacy of their products.

Pharmaceutical companies in India are required to take responsibility for the quality of their products and ensure they are suitable for their intended use.

The World Health Organization (WHO) has recognized the importance of regulatory bodies working together with manufacturers to ensure the quality and safety of medical products.

The Indian government is working to increase investment in public healthcare to meet the demand for quality medical services, especially in rural and remote areas.

India's IT industry is relatively developed, and many hospitals have started to adopt smart systems, such as electronic medical records, remote consultation systems, and digital technologies, to improve medical services.

The World Health Organization (WHO) promotes traditional medicine, including Traditional Chinese Medicine (TCM), Ayurveda, and Unani medicine, and has included traditional medicine in its 26th chapter of the International Classification of Diseases (ICD-11).

The Union government has sought to include Ayurveda and related systems in the 11th revision of the World Health Organisation's International Classification of Diseases (ICD-11) as a supplementary chapter on traditional medicine conditions.

The inclusion of Ayurveda in ICD-11 will provide a common language for health professionals to share standardized information across the world.

The Indian government is working towards scientifically integrating traditional Indian medicine with modern medicine, with the Ministry of Ayush operationalizing 12,500 Ayush health and wellness centers across the country by 2023-24 under the National Ayush Mission (NAM).

Title:

Content: you are here: HomeNewsIndia

Govt working towards scientifically integrating traditional and modern medicine: Sonowal

The ministry is working on operationalisation of 12,500 Ayush health and wellness centres through the support of state and Union territory governments under the National Ayush Mission (NAM) by 2023-24, Sonowal said.

September 07, 2023 / 12:48 AM IST

Ayurveda representational image

India's rich heritage of traditional form of medicine has withstood the test of time and the government has been working towards scientifically integrating it with modern medicine, Union Ayush Minister Sarbananda Sonowal said on Wednesday.

The Regional Review meeting of National Ayush Mission was ceremonially inaugurated by him along with his deputy Munjpara Mahendrabhai.

During the meeting, representatives of all participating states and Union territories presented detailed presentations on the state of Ayush and progress of leading Ayush programmes under implementation.

Speaking on the occasion, Sonowal said, "Our rich heritage and potential of traditional form of medicine has withstood the test of time in generations of humanity to live a better, healthier and happier life. We must take full advantage of this generous forms of medicine - be it Ayurveda, Siddha, Unani, Yoga, Naturopathy, Sowa Rigpa, or Homoeopathy."

He also said that under the visionary leadership of Prime Minister Narendra Modi, the government has been working towards scientifically integrating traditional forms of medicine with the modern medicine.

Highlighting the utility of Ayush system of medicine, he further said that it has some robust programmes like Ayurvidya for promotion of healthy lifestyle through Ayush for school children, Supraja for maternal and neonatal intervention, Vayomitra for geriatric issues; prevention and management of Osteoarthritis and other musculo-skeletal disorders, and Ayush mobile medical units.

The ministry is working on operationalisation of 12,500 Ayush health and wellness centres through the support of state and Union territory governments under the National Ayush Mission (NAM) by 2023-24, Sonowal said.

The ministry of Ayush has so far released Rs 719.70 crore to southern states and Union territories - Andhra Pradesh, Karnataka, Kerala, Lakshadweep, Puducherry, Tamil Nadu and Telangana - under NAM since 2014-15, he said, adding it has also supported 17 Integrated Ayush hospitals in the southern states and out of that six are operational as reported by them.

Mahendrabhai stressed on the need to emphasise on outcomes as a more meaningful measure of programme value than output.

"We may have to realign our strategies and techniques to plan, execute and report our performance that facilitates measure of outcomes," the minister of state for Ayush said.

NAM is being implemented with the vision and objectives to provide Ayush health care services throughout the country by strengthening and improving facilities, to provide informed choice to the needy public.

PTI
first published: Sep 7, 2023 12:47 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Several traditional Indian medicines, part of Ayurveda, have been found to be effective in maintaining blood sugar levels in patients with Type 2 diabetes.

Title:

Content: News

Take up pilot project on Ayurveda treatment: MLA Ramdas

August 29, 2022

Mysore/Mysuru: Studies conducted across the world have found that several traditional medicines commonly used in India as part of Ayurveda are effective in maintaining blood sugar levels in patients with Type 2 diabetes.

Ayurveda is a traditional medical system that has been used for thousands of years in India and some of the herbs included are also used in other parts of the world. In this direction, a systematic project must be developed to treat diabetes, suggested MLA S.A. Ramdas. The suggestion was accepted by Ayurveda practitioners and experts in the field.

The MLA was speaking after inaugurating a free Ayurvedic treatment camp organised at the Sri Ganapathy Ashram on Nanjangud Road yesterday. The camp was organised inside the auditorium of Lakshminarasimha Kuteera of the Ashram by the Government Ayurvedic Research Centre and Ayurveda Academy of Chamarajpet in Bengaluru.

Ramdas suggested the doctors and officers launch a pilot project in a particular locality or a Ward and assured of making all facilities on behalf of the Government. He said that the project can be taken up on Sept. 17, the birthday of Prime Minister Narendra Modi for one year to achieve tangible results for the target population, he suggested.

Modern diabetes drugs are known for side effects and toxicity while Ayurveda works by controlling blood sugar and limiting the harmful effects of other drugs. Turmeric, for example, has been used for the treatment of diabetes in Ayurveda and traditional Chinese medicine, he added.

He said new Ayurvedic remedies were still in great demand for treating diabetes because of the limited efficacy and undesirable side effects of current drugs. A multi-pronged and individualised approach must be used to manage health conditions such as lifestyle modification, Ayurvedic detoxifying and purifying therapies and Ayurvedic medicines containing plant, animal, or mineral-origin ingredients, he added.

University of Mysore Vice-Chancellor Prof. G. Hemantha Kumar, Assistant Director of Government Ayurvedic Research Centre Dr. Lakshminarayana Shenoy, Joint Secretary of Ayurveda Academy Dr. Prashanth Ghokale, Junior pontiff of Ganapathy Ashram Datta Vijayananda Theertha Swamiji and others were present.

ABOUT

Mysuru’s favorite and largest circulated English evening daily has kept the citizens of Mysuru informed and entertained since 1978. Over the past 41 years, Star of Mysore has been the newspaper that Mysureans reach for every evening to know about the happenings in Mysuru city. The newspaper has feature rich articles and dedicated pages targeted at readers across the demographic spectrum of Mysuru city. With a readership of over 2,50,000 Star of Mysore has been the best connection between it’s readers and their leaders; between advertisers and customers; between Mysuru and Mysureans.

CONTACT

Academy News Papers Private Limited, Publishers, Star of Mysore & Mysuru Mithra, 15-C, Industrial ‘A’ Layout, Bannimantap, Mysuru-570015. Phone no. – 0821 249 6520

To advertise on Star of Mysore, email us at

Print Editon: [email protected]
For News/Press Release: [email protected]

In what areas have the medical uses of traditional Indian medicine been studied?

What does Berberine, a commonly used herbal material in traditional Indian medicine, treat?

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

Ayurvedic treatment works by controlling blood sugar and limiting the harmful effects of other drugs, unlike modern diabetes drugs which are known for side effects and toxicity.

In what areas have the medical uses of traditional Indian medicine been studied?

Turmeric has been used in Ayurveda and traditional Chinese medicine for the treatment of diabetes.

How is traditional Indian medicine compared with traditional Chiese medicine?

In what areas have the medical uses of traditional Indian medicine been studied?

What is the traditional Indian medical system called?

Around 400 medicinal plants have been identified as having potential anti-diabetic properties, with 21 herbal plants found to have prominent anti-hyperglycemic action.

Title:

Content: Nation

Researchers claim 400 medicinal plants have anti-diabetic properties

X

New Delhi: As a part of its initiatives to reduce the diabetic burden, the scientists have emphasised on exploring the anti-diabetic properties of around 400 medicinal plants to be used in making medicines based on ayurvedic formulations to control type-2 diabetes by reducing sugar level in blood.

According to the researchers from Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry and All India Institute of Medical Sciences, Kalyani, as of now, there are 21 herbal plants, including Vijayasar, Jamun, Cumin, Daruharidra, little gourd, bael, fenugreek, neem, amla, turmeric that have been found to have prominent anti-hyperglycemic action.

Stressing that diabetes cure lies in the nature, the researchers asserted that intensive studies have been done on 21 herbs and in-depth research on at least 400 herbal plants is needed to exhibit their anti-diabetic properties..

As per their research paper, which is published in the World Journal of Diabetes, these medicinal plants have been the basis of many drugs to manage diabetes. The researchers have also cited the example of BGR-34, a herbal formulation developed by the

Council of Scientific and Industrial Research (CSIR), which has been used to manage diabetes.

The herbal drug BGR-34 contains not one, but many active compounds derived from four medicinal herbs daruharidra, gudmar, methi and vijayasar. Apart from this, giloe and majeeth have also been added to increase immunity as well as antioxidants levels, said Dr Sanchit Sharma, executive director, AIMIL Pharmaceuticals.

The study titled “Treatment on Nature’s lap: Use of Herbal Products in the Management of Hyperglycemia” stated

that although partial research conducted on eight plants, including pomegranate, shilajit, bean, tea, ginkgo biloba, and saffron demonstrate anti-diabetic properties,

it emphasised the need for further trials.

A recent study conducted by AIIMS Delhi revealed that BGR-34, an Ayurvedic medicine, not only helps in reducing sugar levels but also addresses obesity.

The researchers also noted that several allopathic drugs used in diabetes management have their origins in herbal remedies.

For instance, metformin, a widely prescribed medication, is derived from the Galega officinalis plant, which

was historically used to treat diabetes in 19th century Europe.

Next Story

In what areas have the medical uses of traditional Indian medicine been studied?

The herbal drug BGR-34, developed by the Council of Scientific and Industrial Research (CSIR), contains active compounds derived from four medicinal herbs: daruharidra, gudmar, methi, and vijayasar.

BGR-34 has been used to manage diabetes and has been shown to reduce sugar levels and address obesity.

In what areas have the medical uses of traditional Indian medicine been studied?

Ashwagandha, a traditional Indian herb, has been proven to reduce anxiety, stress, improve muscle strength, and reduce fatigue symptoms in patients with chronic diseases.

Title:

Content: Tuesday 10 August 2021 1:10 pm

Long Covid cure? Researchers to trial traditional Indian herb treatment

The London School of Hygiene & Tropical Medicine will work with the All India Institute of Ayurveda to determine whether a traditional Indian herb can help people recover from long Covid.

Ashwagandha, commonly known as Indian winter cherry, is traditionally used in the Indian Ayurvedic system of medicine to boost energy, reduce stress and strengthen the immune system.

Experts said recent trials had proven the herb’s efficacy in reducing anxiety, stress, improving muscle strength and reducing fatigue symptoms in patients with chronic diseases.

Long Covid patients can suffer from cognitive dysfunction, poor mental health, extreme fatigue and muscle weakness.

It is estimated these symptoms affect 10 to 20 per cent of Covid survivors and can last for one to three months or longer in many cases.

The study, funded by the Ministry of Ayush of the Government of India, will include a double-blind clinical trial involving 2,000 people living in the UK with long Covid.

Half of the trial participants will take 500mg Ashwagandha tablets twice a day for three months, while the other half will be given a placebo.

Researchers will randomly select participants to have a monthly follow-up of self-reported quality of life, impairment to activities of daily living, mental and physical health symptoms, supplement use and adverse events.

The study is expected to last for over a year.

“Ashwagandha has been shown to reduce symptoms of other conditions that are similar to those of long Covid, so we are hopeful that it will be an effective way to combat the condition,” said Sanjay Kinra, professor in clinical epidemiology at the London School of Hygiene & Tropical Medicine.

The research is also supported by the UK’s All-Party Parliamentary Group on Indian Traditional Sciences and the Traditional Complementary and Integrative Medicine Unit at the World Health Organisation (WHO).

Research is the only way to ensure appropriate integration of traditional medicine knowledge into mainstream medical practice,” said technical officer at WHO Geneva, Geetha Krishnan, who helped to facilitate the research project.

Share

In what areas have the medical uses of traditional Indian medicine been studied?

What does traditional Indian medicine generally treat?

It addresses the physical aspects of health conditions.

It addresses the psychological aspects of health conditions.

What mental health problems does traditional Indian medicine treat?

Support the management of symptoms related to mental health.

A double-blind clinical trial involving 2,000 people living in the UK with long Covid will be conducted to determine the efficacy of Ashwagandha in helping people recover from long Covid.

The London School of Hygiene & Tropical Medicine is working with the All India Institute of Ayurveda to trial a traditional Indian herb treatment, Ashwagandha, for long Covid.

What is the traditional Indian medical system called?

The World Health Organization (WHO) is establishing a new center in India to study traditional medicine, including Indian herbal medicine, and will use modern technologies such as artificial intelligence and big data to study traditional medicine.

Title:

Content: Archive / Lifestyle
The World Health Organization is interested in alternative medicine.
Mohamed Ismail - Cairo - DPA -
Many people use traditional medicine – but what do these methods really do?
A new WHO centre intends to explore this.
The center is based in India, a country where alternative medicine is so important that it even has its own ministry – which specializes in Ayurveda, Yoga, Physiotherapy, Greek Medicine, Master and Homeopathy.
Indian Prime Minister Narendra Modi attended the opening of the centre in Jamnagar in mid-April, saying: “India ’ s traditional medicine system is not just a cure.
It ’ s a comprehensive science of life. ”
According to the World Health Organization (WHO), the Indian government is supporting the centre with US $250 million (230 million euros).
WHO President Tedros Adhanom Ghebreyesus said: “The center aims to be an engine of innovation, moving towards an agenda of evidence, data and sustainability in traditional medicine, ” adding that the center would connect traditional medicine practitioners around the world and help set standards for research.
Traditional medicine is a broad field.
According to the World Health Organization ’ s statement for the center, 80% of the world ’ s population uses traditional medicine, which includes among other things acupuncture, Ayurvedic medicine and herbal blends.
Traditional medicine is also represented in modern science.
According to the World Health Organization, about 40% of all drugs approved today are derived from natural substances.
The discovery of aspirin, for example, is based on ancient recipes made from the bark of the willow tree.
The research for artemisinin for use in the fight against malaria, for which the Nobel Prize was awarded in 2015, began with the study of ancient texts of Chinese medicine.
George Rochmeyer of Cochrane, an international network that provides the scientific basis for decisions in the health field, said it makes sense at least to take a closer look at treatment methods that have been developed over centuries, to verify the reasonableness of these methods, and to conduct clinical studies on them in case of doubt.
Cochrane reviews are systematic reviews that collect all scientific evidence on a specific issue from medicine or other health sciences.
However, Rochmeyer also stressed that besides the examples of traditional methods cited by the WHO, which form the basis of currently developed treatments, there are likely many other examples where traditional methods of careful review have proven ineffective or even dangerous, such as phlebotomy, noting that spending too much money on studies to review a therapeutic practice is always a matter of discretion.
Rochmeyer stated that there are many Cochrane reviews about the use of traditional methods such as acupuncture in certain cases, but: “From my personal experience at Cochrane, I would say that I have not come across many reviews that have shown really compelling evidence for traditional therapeutic practice. ”
This is often due to the fact that when searching for these treatments we find only a few often-poorly conducted studies that cannot prove or disprove any benefit from them – which brings us back to the question of whether the already limited research funds should be invested in a scientifically unreasonable procedure – for example, homeopathy.
Professor Emeritus Edzard Ernst, a longtime professor of alternative medicine at the University of Exeter, noted that while it was necessary to wait and see who would lead the center and what it would do, the WHO press release was full of exaggerations.
The World Health Organization says it also wants to use new technologies at the new center for the study of traditional medicine — via artificial intelligence and big data, for example.
The center is expected to focus on providing a reliable evidence base for policy and standards of traditional medicine practices and products.
In addition, the center is supposed to help countries integrate these practices into their health systems.
You may also read.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Gathering evidence and data to guide policies

The WHO center will provide a reliable evidence base for policy and standards on traditional medicine practices and products.

What is the World Health Organization doing to promote traditional medicine, including Ayurveda?

Gathering evidence and data to guide policies

Establishing rules for the safe, fair, and effective use of traditional medicine

The Indian government is documenting medicinal herbs of tribal communities across the country, with a pilot project completed in Uttarakhand, resulting in a five-volume book series documenting over 1,400 medicinal plants.

Title:

Content: Govt to document medicinal herbs of tribal communities

Centre to document medicinal herbs of tribal communities across country

The union ministry of tribal affairs carried out the initiative in Kerala, Rajasthan, Maharashtra as well as in Uttarakhand

The Centre is working on documenting medicinal herbs and healers of the tribal communities across the country. A pilot from Uttarakhand has been completed, resulting in a five-volume book series of over 1,400 medicinal plants. The exercise, officials said, will be carried out in more states.

The union ministry of tribal affairs carried out the initiative in Kerala, Rajasthan, Maharashtra as well as in Uttarakhand. Apart from documenting the plant and healers, they also documented the Sanskrit names of these plants.

In Kerala, the Amrita Vishwa Vidyapeetham was given the responsibility, All India Institute of Medical Studies Jodhpur in Rajasthan, Pravara Institute of Medical Sciences Ahmedabad for Maharashtra, and Patanjali carried it out in Uttarakhand.

While the others are carrying it out, Patanjali’s series of seven tomes are ready. In the hill state three districts were chosen, which included Pithoragarh and Udham Singh Nagar, all phytodiversity was documented by a team of over 50-50 people over a period of two years.

When asked about the Sanskrit nomenclature, the official said that it was a way of directing attention to the functionality of the plant.

“The National Medicinal Plant Board says there are over 1,500 plants in Uttarakhand, many of which are not even documented. But in three districts alone, we found 900 plants,” a senior official of the ministry said. “Tribal medicine holds considerable interest among researchers.”

Chemical analysis of all these plants was carried out, to find the active ingredient in the plant, with the help of an HPLC machine, officials said. Apart from that, samples of these were preserved, along with data on their therapeutic use. The official said that permissions from the biodiversity board were also taken.

In addition to that, the Hyderabad-based National Institute of Pharmaceutical Education and Research (NIPER) carried out a similar exercise in their areas where they found three medicinal plants, which when combined can be a cure for malaria. A similar exercise was carried out by the same team in the Rashtrapati Bhawan as well.

Healers in tribal communities in the areas that use these plants were also documented, along with data of their areas of expertise. In all, 750 healers were documented.

Officials said that after the successful pilot, the ministry has sent it to the AYUSH ministry, urging them to take it further across the country using SC/ST components from their funds. Officials also said that details of these plants will be put up online.

Check out DH's latest videos

Check out DH's latest videos

Get a round-up of the day's top stories in your inbox

Check out all newsletters

Get a round-up of the day's top stories in your inbox

The National Institute of Pharmaceutical Education and Research (NIPER) found three medicinal plants in their area that, when combined, can be a potential cure for malaria.

The Council of Scientific and Industrial Research (CSIR) has developed a herbal formulation called BGR-34, which contains active compounds derived from four medicinal herbs, to manage diabetes.

In what areas have the medical uses of traditional Indian medicine been studied?

The Ministry of Ayush has supported 17 Integrated Ayush hospitals in southern states, with six currently operational.

Maharishi Ayurveda Hospital is a NABH-approved Ayurvedic hospital in India with a 30-year legacy, and offers a range of Ayurvedic treatments, including Abhyanga, Shirodhara, and Swedan.

Title:

Content: Maharishi Ayurveda Hospital: An Exclusive Daylong Immersion into Holistic Well-being

Published on Dec 19, 2023 07:08 PM IST

This institution stands as a beacon of holistic healing, inviting individuals to embark on a profound journey towards wellness

ByHT Brand Studio

As one of the pioneering NABH-approved Ayurvedic Hospitals in India, nestled between 15 acres of greenery within Shalimar Bagh of North Delhi, Maharishi Ayurveda Hospital boasts a 30-year legacy. Over this time, guests from over 100 countries have been welcomed, experiencing unparalleled care and high success rates coupled with utmost satisfaction. Rooted in the visionary philosophy of His Holiness Maharishi Mahesh Yogi Ji, this institution stands as a beacon of holistic healing, inviting individuals to embark on a profound journey towards wellness.

Beyond a healthcare institution, the wellness hospital embodies a commitment of establishing a society free from ailments, woven into every aspect of its existence.

IPL 2024 Auction is here! Catch all the updates LIVE on HT. Join Now

Let's unveil a day within its tranquil confines, where ancient wisdom meets contemporary care.

Arrival and Initiation at Maharishi Ayurveda Hospital

Upon arrival at Maharishi Ayurveda Hospital, guests are warmly received by the hospital's dedicated driver, ensuring a seamless transition from the airport to the tranquil facility. As guests step onto the premises, a sense of serenity envelops them. Check-in procedures are conducted efficiently, allowing guests to swiftly transition into the healing ambiance. The traditional welcome, marked by the application of a ceremonial tika and the offering of a tulsi mala, symbolizes the initiation of a wellness journey. To familiarize guests with the hospital's layout and facilities, the attentive staff offers a guided tour, acquainting them with key spots and amenities, allowing for a smooth settling-in process amidst the peaceful surroundings. This initial interaction sets the tone for a stay focused on rejuvenation and a holistic wellness experience.

Awakening to Serenity: The Art of Accommodation

As dawn breaks, guests arise to the embrace of specially designed rooms, harmoniously blending Ayurvedic principles with modernity. Bamboo whispers tranquility, while the morning herbal elixir sets the tone for a day of rejuvenation. The teachings of Maharishi Mahesh Yogi Ji provide a contemplative start, fostering a deeper understanding of Ayurveda's timeless wisdom.

Yoga for the Soul: Morning Routines Redefined

The day unfurls with the graceful practice of yoga in the Yoga Hall, where guests delve into Maharishi Yoga Asanas curated to their body's needs. Each posture narrates a tale of therapeutic benefits, guiding individuals on a personalized path to holistic healing.

Blessings of Harmony: A Sacred Morning Ritual

Within the hospital's divine space – ‘Mandir’, the resonance of chanting mantras infuses the environment with positive vibrations. Here, morning blessings are bestowed, setting intentions for a day steeped in health and wellbeing—a powerful spiritual prelude to the day's journey.

Customized Care: Tailored Treatments Unveiled

Guided by the art of pulse diagnosis, tailored treatment plans unfold, addressing individual body constitutions, doshas, and health nuances. The day unfolds with an array of therapies—Abhyanga, Shirodhara, Swedan, and many more—each a testament to personalized care and restoration. Afternoons bring focused therapies targeting specific concerns like cervical or back pain, integrating bespoke Vasti therapies and individualized herbal remedies.

Gastronomic Harmony: Nourishment Rooted in Ayurveda

Meals resonate with Ayurvedic principles, showcasing satvik gastronomy crafted from locally sourced, nourishing ingredients. Maharishi Gandharva Veda music provides a harmonious backdrop, elevating the dining experience as guests indulge in meals tailored to their health goals.

Empowerment through Knowledge: Enlightening Evenings

As twilight descends, the hospital's Conference Hall transforms into a haven of enlightenment. Expert-led sessions unravel the layers of Ayurveda, encompassing Transcendental Meditation, Ayurvedic culinary arts, and the essence of Sthapatya Veda (Vaastu). These sessions empower guests with profound insights into holistic living.

Nature's Embrace and Leisure: Twilight Moments

Amidst lush greenery, guests meander through the campus, seeking solace in serene gardens and the gentle ambiance of the gaushala. The evening unfurls moments of camaraderie through indoor games, fostering connections amidst shared laughter.

Evening Rituals of Harmony: Embracing Ayurvedic Wisdom

The night envelops guests in the embrace of night therapies with soothing touches of mukh lepa or pad abhyanga paves the way for a restful slumber, aligning with Ayurvedic wisdom for a peaceful night's rest.

An Odyssey to Wholeness

Maharishi Ayurveda Hospital isn't just a sanctuary—it's an odyssey toward complete wellness. Here, the essence of Ayurveda intertwines seamlessly with modern comforts, offering guests a transformative voyage. Each moment, from tailored treatments to enlightening sessions and tranquil twilight, resonates as a testament to the timeless wisdom of Ayurveda, guiding guests toward holistic wellbeing.

Disclaimer: This article is a paid publication and does not have journalistic/editorial involvement of Hindustan Times. Hindustan Times does not endorse/subscribe to the content(s) of the article/advertisement and/or view(s) expressed herein. Hindustan Times shall not in any manner, be responsible and/or liable in any manner whatsoever for all that is stated in the article and/or also with regard to the view(s), opinion(s), announcement(s), declaration(s), affirmation(s) etc., stated/featured in the same.

Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! -Login Now!
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, December 19, 2023
Start 14 Days Free Trial Subscribe Now

What is the traditional Indian medical system called?

Ayurvedic treatment has reached the global level, and medications based on Ayurveda are being backed by researchers from all over the world.

Title:

Content: Begin typing your search...

Embrace Motherhood with Ayurveda

Ayurveda, the ancient Indian system of medicine, has been used for thousands of years to treat a wide range of health conditions, including all types of Gynaecological disorders.

Representative image

  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo
  • Whatsapp
  • Telegram
  • Linkedin
  • Print
  • koo

NEW DELHI: Infertility is an inability of a couple to conceive naturally which is one of the burning global issues today. The stress of the non-fulfilment of a wish to have a child, has been associated with emotional squeal such as anger, depression, anxiety, marital problems and feelings of worthlessness among the parents. According to WHO, one in six people globally are affected by infertility which accounts to 17.5 per cent of the world's entire adult population.

Ayurveda, the ancient Indian system of medicine, has been used for thousands of years to treat a wide range of health conditions, including all types of Gynaecological disorders and reproductive health issues like infertility. Ayurveda views infertility as a result of an imbalance in the body's doshas, or energy systems. By rebalancing these doshas, Ayurveda aims to restore fertility and promote overall health.

Role of Ayurveda in the Journey of Motherhood

Ayurveda has great potential to address fertility related issues. The very effective way to treat infertility is the combination of the right Ayurvedic herbs and healthy Diet Lifestyle.

Ayurvedic Herbs to treat infertility

Ayurvedic scriptures have detailed descriptions about different herbs that can help in each step of conceiving. It offers great benefits to achieve proper egg growth, improve egg quality, timely ovulation, fertilisation, implantation, maintaining healthy pregnancy etc. These herbs help to restore balance of the doshas to impart strength and to support reproductive functions at each step. However, these should be combined with Diet and lifestyle changes for best results. Here are some Ayurvedic herbs having great potential to treat infertility.

Putrajivak: Putrajivaka has been traditionally associated with enhancing fertility big time. This is a very powerful herb that balances hormones, improves egg quality and ensures strong and healthy implantation

Shivlingi: Shivlingi is primarily used for its ability to treat female infertility and promote conception. The seeds of the plant have properties that help improve the egg quality, which is a great concern today.

Jeevanti: Jeevanti is great at improving the quality of the inner lining of the uterus. It makes sure the embryo gets proper nutrition after implantation.

Ashwagandha: Ashwagandha balances hormones and works as a uterine tonic, strengthens uterine muscles, improves egg quality, improves libido, reduces stress, and improves reproductive health.

Shatavari: Shatavari provide nutrition to the reproductive system , balance hormones, improve the uterine atmosphere, help improve egg size.

Gokshura: It is believed to improve sperm count and quality, and to increase testosterone levels in men. In females, it maintains healthy vaginal PH, and relieves inflammation to facilitate natural conception.

Triphala: Triphala is a combination of three fruits that is commonly used in Ayurveda for a variety of health conditions. It is the best combination for Uterine detox.

Diet and Lifestyle

Ayurveda emphasises the importance of a healthy diet and lifestyle in promoting fertility. A balanced diet that includes fresh fruits, vegetables, and whole grains can help improve reproductive health by providing the necessary nutrients for the body. Healthy sleep cycle, staying relaxed & positive, moderate exercise every day are some of the very important lifestyle factors influencing fertility positively.

Right combination of pure herbs like Jeehv fertility supplement along with a healthy diet and lifestyle can deal with fertility issues naturally and without any side effects. It helps improve your chances of conceiving naturally manyfolds.

Ayurvedic treatment today has reached the global level and medications based in ayurveda are being backed by researchers from all over the world. Ayurveda offers a holistic approach to treating infertility by addressing the root cause of the problem and promoting overall health and well-being. Every woman trying to conceive must benefit from this powerful, effective and side effect free, natural medicine.

Next Story

What treatment did Former Kenyan President's daughter Rosemary Odinga get that helped her regain eyesight?

Traditional Indian medicine Ayurvedic treatment.

What does traditional Indian medicine generally treat?

The Indian government has allocated around $80 million to the Ministry of Health to strengthen the regulatory system for drugs, including creating laboratories for testing new drugs and modernizing existing ones.

Title:

Content: In India, of the nearly 89,000 drug samples tested, more than 2,500 failed to meet the standards.
Such data was presented by the Minister of health of the country Mansuh Mandavia, reports Reuters.
About 380 samples were found to be fakes.
The government of India has allocated about $80 million to the Ministry of Health to strengthen the drug regulatory system, including the creation of laboratories for testing new drugs and the modernization of existing ones.
Over the past 10 years, exports of pharmaceuticals from India more than doubled to $24.5 billion in 2021-2022.
However, the deaths of 20 children in Uzbekistan and 200 in the Gambia and Indonesia after taking children's antipyretic syrups from Indian companies, in which ethylene glycol was found, undermined India's image as a "world pharmacy," the newspaper notes.
Last week, the Indian manufacturer Global Pharma Healthcare was also forced to withdraw all batches of its eye drops, as the United States registered 55 cases of side effects associated with taking the drug, including eye infections, irreversible loss of vision and one death, writes The Hindu BusinessLine.
At the end of January, the World Health Organization called on drug manufacturers to strengthen quality control of raw materials and the manufacturing process.
Governments should enact laws to combat substandard and falsified medicines and strengthen market surveillance, including informal surveillance.

The World Health Organization (WHO) has called on drug manufacturers to strengthen quality control of raw materials and the manufacturing process.

The Indian pharmaceutical industry relies heavily on data to drive its operations and is vulnerable to cyber threats, including ransomware and phishing.

Title:

Content: Express Pharma

Regulatory measures for cybersecurity in India’s pharmaceutical industry

By Sidharrth Shankar, Partner, JSA Advocates and Solicitors

0 4

Pharmaceutical companies face unique challenges due to their rapid digital transformation, adopting Internet of Things (IoT), Artificial Intelligence (AI), and blockchain technologies. However, these technologies, while being beneficial, introduce significant cybersecurity risks that need to be managed effectively. The rise in cyber threats, including ransomware and phishing, threatens sensitive data related to clinical trials, patents, and patient information, potentially eroding customer trust and brand reputation.

The regulatory landscape in India mandates stringent cybersecurity measures to protect sensitive data. Recent regulations such as the ‘National Cyber Security Policy’ and the ‘Data Protection Bill’ set high standards for cybersecurity practices to prevent breaches and avoid severe penalties.

The Indian pharmaceutical industry, vital for both domestic and global healthcare, relies heavily on data to drive its operations. Recent cyberattacks on major entities like Sun Pharma, AIIMS, and Safdarjung Hospital underscore a critical vulnerability: inadequate cybersecurity infrastructure. With over 1.9 million attacks in 2022 alone, the urgency for a comprehensive cybersecurity overhaul is evident.

Pharmaceutical manufacturing executives are facing a complex array of cybersecurity challenges, driven primarily by the sector’s increasing digitalisation and the high value of intellectual property. An overview of these challenges and some practical strategies to enhance resilience illustrates the current difficulties.

Cybersecurity Challenges

Intellectual Property Theft: Pharmaceutical companies invest heavily in research and development. As such, the theft of intellectual data such as clinical trial data, drug formulations, and manufacturing techniques can be devastating.

Supply Chain Vulnerabilities: The pharmaceutical supply chain involves numerous stakeholders ranging from raw material suppliers to distribution networks. Each node in this chain symbolises a point of vulnerability that allows cyber attackers to infiltrate systems.

Regulatory Compliance: The pharmaceutical industry is heavily regulated. Non-compliance due to a cybersecurity breach can lead to severe penalties, loss of licence, or other regulatory actions.

Legacy Systems: Many pharmaceutical companies still rely on outdated technology systems that are not equipped to handle modern cyber threats. These systems often lack the security features necessary to protect against sophisticated attacks.

Ransomware Attacks: As seen in recent years, ransomware can cripple manufacturing operations, leading to significant financial losses and disruption of critical healthcare supplies.

Security Measures

Despite these challenges, the pharmaceutical sector has not historically been at the forefront of cybersecurity. However, high-profile cyberattacks have led to a heightened awareness and prioritisation of the need for enhanced security measures.

Cyber threats make pharmaceutical companies vulnerable to identity theft and evolving attack vectors. As companies increasingly digitise, more of their valuable data is stored online, heightening their appeal to cybercriminals.

Pharmaceutical companies also manage many devices that collect and store health and patient data online. They utilise big data tools and IoT, which, while increasing risks, underscores the importance for organisations to integrate security and privacy by design.

Privileged access, which involves granting higher access levels to certain files or systems, enables organisations to secure applications and IT infrastructure, operate more efficiently, and protect their most sensitive data and critical infrastructure. This access can be extended to both human users and non-human users, such as applications and machines.

The pharmaceutical industry’s cybersecurity is threatened by a wide array of risks and attack vectors, including those from third-party vendors. Pharmaceutical organisations depend heavily on these vendors for daily functions such as research, development, and logistics. Any security breach within these third-party services can lead to significant data loss for the pharmaceutical company. Healthcare cybersecurity relies on robust processes and practices to meet strict regulatory compliance requirements.

Phishing attacks, often delivered via email, persuade individuals to click on malicious links, enabling attackers to compromise email accounts and steal data, intellectual property, and funds from banking accounts.

Human error and negligence continue to be significant factors in data breaches and cyberattacks across all sectors. Ensuring employees adhere to protocols for data protection and do not use unauthorised software is critical to preventing cyber incidents.

Mergers and acquisitions in the pharma industry also pose a risk to confidential data if not managed properly due to potential data protection lapses and insufficient due diligence.

The adoption of new technologies in the pharmaceutical industry carries inherent security risks. Therefore, companies must ensure that all new technologies are properly secured and do not introduce vulnerabilities that hackers could exploit. Pharma companies need adaptable yet strong cybersecurity practices and protocols to protect their new technologies, allowing them to monitor threats, identify vulnerabilities, and safeguard intellectual property.

Hand & Glove

A pressing concern in this digital transformation is the protection of sensitive health data. With regulations such as the Personal Data Protection Bill, which is due to become law, pharmaceutical companies must ensure they comply with strict data protection standards. These regulations mandate how data should be securely handled and how breaches should be reported. Non-compliance could not only lead to significant penalties, but, more critically, it could also undermine public trust—a commodity that is as valuable as any pharmaceutical product itself.

Collaboration between the government and the private sector is crucial to fortifying the cybersecurity infrastructure. Initiatives that include the development of more robust cybersecurity frameworks, regular audits of cybersecurity practices, and fostering a culture of cyber resilience within organisations would be beneficial. Government agencies could also play a crucial role by facilitating the exchange of threat intelligence and best practices among companies and international bodies.

Moving Forward

Pharmaceutical companies must adopt a forward-thinking cybersecurity strategy. This involves investing in sophisticated security measures such as multi-factor authentication, firewalls, and intrusion detection systems. Implementing a zero-trust framework and developing comprehensive third-party risk management programs are also essential to protect the industry’s digital assets.

Enhancing cybersecurity is not only a regulatory necessity but also a strategic essential that will increase the pharmaceutical industry’s resilience against cyber threats, ensuring its continued growth and contribution to global healthcare.

The pharmaceutical sector is a repository for highly sensitive data and cutting-edge technology, making it a prime target for cybercriminals. Cybersecurity within the pharmaceutical sector is under threat as these organisations house sensitive patient information, patented drugs, and detailed records of clinical trials and research projects.

With rapid technological advances, the increase in automated tools, and the reliance on third-party vendors, pharmaceutical companies face significant cybersecurity challenges. A crucial task for securing information in the pharmaceutical industry is to implement security protocols and robust, comprehensive strategies that protect digital assets and minimise cyber-attacks on these companies. This is essential to prevent catastrophic data loss that could undermine consumer and patient trust, damage the brand image, and lead to plummeting share prices.

Road Ahead

It is clear that the cybersecurity ambience of the pharmaceutical industry in India i

The National Cyber Security Policy and the Data Protection Bill in India set high standards for cybersecurity practices to prevent breaches and avoid severe penalties.

The Indian government is planning to revise Schedule M of the Drugs and Cosmetics Rules, 1945, to bring it closer to World Health Organization (WHO) standards.

Title:

Content: Schedule M likely to be revised to bring it closer to WHO standards

The draft rules, still under consideration, include provisions to strengthen quality control and the safety of drugs manufactured in India

Anjali SinghSanket Koul New Delhi/Mumbai

4 min read Last Updated : Oct 1 2023 | 7:49 PM IST

A notification for revising Schedule M (of the Drugs and Cosmetics Rules, 1945) may be released soon to help Indian pharma companies adopt good manufacturing practices (GMP) as prescribed by the World Health Organization (WHO), a senior government official said.

The Drugs Controller General of India (DCGI), Rajiv Singh Raghuvanshi, said at a conference revised Schedule M would bring the industry on a par with global standards.

The move has come after the WHO raised concern when cough syrups exported by some Indian companies were allegedly responsible for the deaths of children abroad.

Adopting GMP in accordance with revised Schedule M was made mandatory for all pharma companies, including micro, small and medium companies, last month. Manufacturers having an annual turnover of less than Rs 250 crore had to complete their certification process within 12 months, whereas those with over Rs 250 crore were given six months to do so.

The draft rules, still under consideration, include provisions to strengthen quality control and the safety of drugs manufactured in India.

Meanwhile, to explain these changes and ensure compliance with them, the Central Drugs Standard Control Organisation (CDSCO) has conducted a one-day workshop in Mumbai.

Eswara Reddy, joint drug controller, CDSCO, said one of the most important changes proposed in the new draft rules was introducing a comprehensive system for change control.

“Under the current rules, manufacturers are only required to notify the CDSCO of significant changes to their manufacturing processes. The new draft rules would require manufacturers to classify all changes as minor, major, or critical, and to implement appropriate controls for each type of change. This would help to ensure that any changes in manufacturing processes are evaluated and managed to minimise the risk of product contamination or quality problems,” Reddy said.

The revision introduces the pharmaceutical quality system, quality risk management, product quality review, and qualifying and validating equipment, change control management, self-inspection, and stability studies in accordance with recommended climate conditions. Another important change proposed in the new draft rules is that manufacturers need to have a qualified and validated computerised storage system for all drug products, ensuring that drugs are stored in right conditions and that their quality is maintained throughout the supply chain. The draft rules also introduce validated cleaning procedures, working standards, and identity tests for starting materials. Additionally, they extend the retesting period for materials and call for including weighing areas, audit trails, and measures to prevent cross-contamination. Detailed guidelines for good production practices, deviation control, and equipment storage after cleaning have also been incorporated.

The ongoing risk-based inspections might have prompted the government to reassess the current GMP regulations and quality management systems followed by pharmaceutical manufacturers.

GMP, which include standards for materials, methods, machines, processes, personnel, and facilities, was first introduced in 1988 under Schedule M. This is the first amendment since June 2005.

The government has been trying to implement regulatory reforms in the pharma sector for the past few months. This includes regular meetings with state controllers to ensure harmonisation in the workings of the departments. Highlighting India’s desire to be a permanent member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, the DCGI said: “We have been accorded observer status but the ball is in their court as far as inviting us for membership is concerned.”

The DCGI said 99 per cent of the spurious products found during the past two to three years were among the top 300 medicine brands in India.

To counter this, the CDSCO will develop a digital regulatory ecosystem to look into grievances and impacts caused by the spurious industry.

The CDSCO has raided several labs that made spurious medicines.

Topics :World Health OrganisationPharma CompaniesMSMEspharmaceutical firms

First Published: Oct 1 2023 | 7:38 PM IST

Next Story

The revision aims to strengthen quality control and safety of drugs manufactured in India.

The Central Drugs Standard Control Organisation (CDSCO) is the national regulatory authority in India responsible for ensuring the quality, safety, and efficacy of drugs, including herbal medicine products.

Title:

Content: Thursday, Oct 06, 2022

Syrups flagged by WHO not sold in India, only exported to Gambia: Govt

The manufacturers had been given special approval for export against purchase order placed by Gambia. “These drugs are not sold in India, so the company needed a special approval,” said an official investigating the matter.

Maiden Pharmaceuticals Limited factory in Sonepat district. (PTI Photo)

After an alert about four syrups was raised by World Health Organization (WHO) on Wednesday, Indian authorities investigating the matter said the sales of the particular products were limited to Gambia.

“These 04 drugs are not licensed for manufacture and sale in India. In effect, none of these four drugs is sold domestically,” said a release from the union health ministry.

The manufacturers had been given special approval for export against purchase order placed by Gambia. “These drugs are not sold in India, so the company needed a special approval,” said an official investigating the matter.

Following the death of 66 children in Gambia, the WHO has raised an alert for four India-manufactured fever, cough and cold syrups, urging people to not use them. All the four syrups — Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup — were manufactured by Haryana-based Maiden Pharmaceuticals.

Subscriber Only Stories

As per information sent to Indian authorities, the intra-government organisation tested 23 samples of the syrup of which four were found to contain di-ethylene glycol and ethylene glycol, which are toxic for humans and can lead to acute kidney injury and kidney failure in children.

The ministry also urged the WHO to share report on causal relationship — confirmation that the syrups led to the deaths in Gambia — at the earliest. A release from the union health ministry said: “The exact one-to-one causal relation of death has not yet been provided by WHO to CDSCO. As a robust National Regulatory Authority, CDSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question.”

Action against the company

With the products not meant for Indian markets, there weren’t any market samples that could be tested by Indian authorities. A joint team of Central Drugs Standard Control Organisation and Haryana State drug regulator investigating the matter have lifted the controlled samples — samples from the batches sent to Gambia stored by the manufacturers as part of quality control procedures.

Advertisement

The samples have been sent to regional drug testing lab in Chandigarh. According to officials who are part of the investigation in India, even if the control samples are found to be contaminated, the authorities are unsure what action can be taken against the company.

“WHO has shared its findings, but we also have to see whether the control samples contain the contaminants in question. If we do find contaminants, proportionate action will be taken against the company, which may include suspension of the licence to export the drug. However, we are unsure whether we can initiate criminal action against the company because the deaths did not happen in India,” the official said.

The current Drugs and Cosmetics Act has provisions for up to three-year imprisonment, while the proposed Bill has increased this to a minimum of 10 years. In a release, the health ministry said: “It is a usual practice that the importing country tests these imported products on quality parameters and satisfies itself as to the quality of the products before the importing country decides to release such products for usage in the country.”

First published on: 07-10-2022 at 01:31:46 am
Next Story

Nearly half of work on Ayodhya Ram Mandir complete: Adityanath

Advertisement
Advertisement
Advertisement
Advertisement

The CDSCO has requested the WHO to share a report on the causal relationship between certain syrups and the deaths of children in Gambia.

The Indian government has set new manufacturing standards for pharmaceutical companies in the country to ensure the quality, safety, and efficacy of their products.

Title:

Content: India sets new standards for drug manufacturing after child deaths
T + T - normal size
India ’ s pharmaceutical companies must set new manufacturing standards this year, a government notification said on Saturday, but small companies asked for a delay due to the debt burden.
Indian Prime Minister Narendra Modi has stepped up vetting of pharmaceutical factories to salvage the reputation of the $50 billion industry, following a spate of deaths outside India linked to drugs manufactured in India since 2022.
The notice, dated December 28, states: “The manufacturer must take responsibility for the quality of the products to ensure that they are suitable for their intended use, comply with licensing requirements and do not expose patients to risk. ”
The notification added that companies must market the finished product after achieving "satisfactory results" in testing the ingredients.
The health ministry said in August that inspections at 162 pharmaceutical plants since December 2022 revealed "a lack of testing for incoming raw materials."
Fewer than a quarter of India ’ s 8,500 small pharmaceutical factories comply with international standards for the manufacture of medicines set by the World Health Organization (WHO), the ministry said.
The notification stated that these concerns should be addressed by major pharmaceutical companies within six months and by small manufacturers within 12 months.
Small businesses have asked for an extension of the deadline, warning that the investments needed to meet the standards will cause nearly half of the factories to close because they are already mired in debt.
The World Health Organization and other health agencies have linked an Indian cough medicine to the deaths of at least 141 children in Gambia, Uzbekistan and Cameroon.
Email

Pharmaceutical companies in India are required to take responsibility for the quality of their products and ensure they are suitable for their intended use.

The World Health Organization (WHO) has recognized the importance of regulatory bodies working together with manufacturers to ensure the quality and safety of medical products.

The Indian government is working to increase investment in public healthcare to meet the demand for quality medical services, especially in rural and remote areas.

India's IT industry is relatively developed, and many hospitals have started to adopt smart systems, such as electronic medical records, remote consultation systems, and digital technologies, to improve medical services.

Title:

Content: India ’ s medical facilities speed up the development of intelligent system to help rural remote consultation
Author ： 01 Source of Medical Clinic
Published: Updated:
For many Hong Kong people, India may look like a relatively backward and populous country, with a population of 1.4 billion, and it is hard to imagine how the local medical system can accommodate such a large population.
The author went to the local area to participate in the large-scale international engineering alliance conference, found that the local medical facilities are developing rapidly, the number of hospital beds in the country has increased by 40% in the past 10 years, and some large hospitals have added intelligent equipment to assist in the diagnosis and daily operation of the hospital.
If you have the ability to increase investment in the future, coupled with the development of local information technology, and gradually trend towards intelligent development, I believe that it is not difficult to see the emergence of comprehensive intelligent hospitals, so that patient services are more efficient and no longer subject to geographical restrictions.
Author: Yuan Pak Leung, Former President of the Institution of Senior Engineers and Engineers
I am the Vice-Chairman of the International Engineering Technologists Agreement and the Chairman of the British delegation chaired a review meeting of the agreement in New Delhi, India.
As the Vice President of the International Engineering Technologists Agreement (IETTA), I went to New Delhi, India, to attend this year ’ s IETTA conference hosted by my host, and also chaired the annual meeting held in India in the same capacity as the chairman of the Seoul Accord.
Over the course of more than 10 days, I have met many people in the engineering industry from all over India, some from the medical industry, so I have the opportunity to learn more about the development of local hospital facilities.
According to the local industry, the number of hospitals and beds in India has increased rapidly over the past decade. For example, from 2010 to 2020, the total number of beds in the country has increased from about 1.2 million to more than 1.7 million, an increase of more than 40%.
As of 2023, the market share of hospital spending across India, including public and private hospitals, is in the hundreds of billions of dollars. However, the number of beds per 1,000 people is still relatively low globally.
On both sides of a highway in New Delhi, I saw 20 medical statues placed by Yatharth Hospital to thank and honor the work of “anti-virus warriors ” during the COVID-19 pandemic.
However, unlike in Hong Kong, Indian hospitals are dominated by private hospitals, accounting for 70% of the total number of beds.
Some people in the local industry admit that this reflects that the investment in public health care is not enough at present, but it is understood that the local public sector is trying to catch up with the demand, but the demand is too large and it is difficult to meet 100%.
Therefore, ensuring equitable access to quality health care is a challenge for local authorities, especially in remote areas such as mountains or rural areas.
It is said that there is a medical culture in India with a long history in Asia that can alleviate some of the medical needs of the general population.
It is a system of traditional medicine called Ayurveda, which is called Ayurveda. It is composed of two Sanskrit words, ayur refers to life and veda means knowledge.
Together, they mean “knowledge of life ” and are considered to be one of the most ancient forms of holistic natural medicine in the world, originating from ancient India, for thousands of years. Ayurveda and Chinese medicine have many things in common, especially the focus of both is on the patient, not on the disease.
Its core concept is to maintain their own spiritual balance and harmony, will make people physically healthy, the theory that life should avoid excessive hyperactivity, because it will lead to too much stomach acid, so that people become irritable, anxiety and other problems.
Excessive hyperactivity can also affect the joints, mucous membranes, and fats that protect our body structure, leading to obesity and depression, and people ’ s physical and mental activities, including breathing, blood circulation, and nervous system if over-regulation, can bring anxiety, constipation, joint pain and so on.
Ayurveda emphasizes the uniqueness of the individual and regulates and prevents diseases according to the physical and psychological characteristics of the individual.
In general, Ayurveda believes that a variety of herbs, spices, minerals, etc. can be used to treat diseases, and diet therapy is used to adjust the diet according to the body, while lifestyle adjustments include yoga, meditation and massage.
In addition to its unique medical concept, India ’ s relatively advanced information technology development, I believe it can also be an opportunity to make up for the lack of medical services.
In fact, many local hospitals have begun to add intelligent systems, such as electronic medical record system, remote medical system and the application of digital technology, which improve the ability of doctors to treat patients, and increase the ability of remote consultation, so that patients in remote rural areas can benefit.
In order to increase the efficiency of consultation and make more accurate diagnosis, local doctors will also use wearable devices to understand the patient ’ s physical condition, and even use intelligent systems to help make clinical decisions.
The conference hotel I stayed at offers authentic Indian Ayurveda healing massages, including the Ayurveda oil drip, which is said to be effective in helping to relieve stress.
The author believes that Hong Kong and India have very different cultural backgrounds, but they are also working hard to promote the development of intelligent hospitals.
However, some local technology industry people pointed out that, regardless of whether the two places or other regions should pay more attention to the convenience and efficiency of intelligent systems, there are opportunities for network security risks or personal data leakage, so there are challenges when using different smart technologies.
With the rapid development of the local medical system with advanced technology, I believe that if the world can introduce more intelligent elements in its medical system, and continue to invest in it, coupled with the policy support of government departments, we can cite each other, exchange learning and practice verification, I believe that it is not difficult to build a fully intelligent hospital in the future, and hope that this efficient service model can meet the increasing medical demand of society.
"01 Medical Clinic" cooperates with senior engineer Yuan Pak Leung to launch a column "Source Road Has You" every Monday to share the big and small things of engineering and medical care.
Yuan Pak Leung has always been committed to promoting the professional development of the engineering profession and is the former President of the Hong Kong Institution of Engineers.
The decades of professional journey are worth remembering, and I am convinced that the latter may understand the key points of the engineering profession.
If you have the source, let everyone experience it together.

The World Health Organization (WHO) promotes traditional medicine, including Traditional Chinese Medicine (TCM), Ayurveda, and Unani medicine, and has included traditional medicine in its 26th chapter of the International Classification of Diseases (ICD-11).

Title:

Content: Free Square 》 Expert advice in the field of medicine and health in an aging society
◎ Chen Chi-fang
On January 26, the medical policy meeting discussed the possible adjustment of the ceiling number of medical centers, and the Ministry of Health and Welfare announced the nursing night shift allowance. On January 31, the Ministry of Education will convene to discuss the enrollment of Chinese medicine departments.
The Government continues to be concerned about medical issues.
The world ’ s first medical specialty group was the American Academy of Ophthalmology, founded in Pennsylvania in 1916. The National Federation of Specialty Medicine was founded in 1933, with a total of 24 specialties developed over a century by the original 10 members of the unit.
At present, there are 23 Western medicine specialties and 11 dental specialties in Taiwan. In recent years, the specialties have been regrouped and combined, including the establishment of Hospitalist, an integrated medical department, and cross-disciplinary care planning, all of which are adjusted in response to the aging society.
The Taiwan Medical Law includes Western medicine, dentistry, Chinese medicine, and traditional Chinese medicine academic communities. In the late 20th century, six of them were born in response to the election of the Association. In recent years, the number of training personnel after graduation of Chinese medicine in Taiwan is insufficient, the teaching materials are not yet in place, the department adjustment and the ratio of teachers and students are seriously behind the same group of doctors and doctors. Limit the development of medicine.
"Chinese Medicine Development Law" The author actually participated in it from zero to there, the spirit and content of the bill did not talk about Chinese medicine specialties, some Chinese medicine societies misinterpreted the bill, it is regrettable.
At present, due to the controversy of university medical departments under the wave of childrenization, the amount of training after graduation, and the low value of practicing health insurance, medical care in an aging society needs to be adjusted with the times.
Every time I participate in the meeting, I have a headache, because some groups intentionally or unintentionally mislead the competent authority, ignore the practice investigation, and hinder the national right to health.
Traditional Chinese medicine, surgery, orthopedics, etc. in Japan today, and Taiwan and Korea have their own departments of Chinese medicine, Korean medicine, Chinese medicine, and Korean medicine, which coexist with Western medicine.
Taiwan and Japan have developed unique concentrated biopharmaceutical granule preparation technology.
No matter what kind of medicine, it is to deal with health problems.
At present, the World Health Organization (WHO) promotes traditional medicine, including TCM in East Asia, Ayurveda in South Asia, and Unani medicine in Europe and Africa. The 11th revision of the International Classification of Diseases (ICD-11) was also considered by the 72nd World Health Assembly on May 25, 2019.
Taiwan ’ s medical satisfaction ranks first, and the Chinese medicine practitioners who work with Western medicine to treat patients and save others can still help in the post-epidemic era. The sound development of medical care is by no means hastily on the road to specialty, or the total amount of health insurance will be shifted down!
The competent authority should fully discuss the views of all parties.
Only a sustainable system can benefit the country and the people.
(The author is president of the Taiwan Society of Traditional Chinese Medicine)
No need to smoke, no need to grab, now use the APP to watch the news, guarantee the daily winning point I download the APP
I've added friends, thank you.
Welcome to [Free Commentary]
It's a compliment. Good.
It has been praised, thank you.
Editor 's Choice

Is traditional Indian medicine Ayurveda certified by the World Health Organization?

What is the traditional Indian medical system called?

The Union government has sought to include Ayurveda and related systems in the 11th revision of the World Health Organisation's International Classification of Diseases (ICD-11) as a supplementary chapter on traditional medicine conditions.

Title:

Content: Traditional Indian medicine set to make a global debut, seeking inclusion in WHO’s ICD-11 list

The inclusion of Ayurveda and related systems on the WHO list will provide it with a common language that allows health professionals to share standardised information across the world

October 14, 2023 06:17 pm | Updated 06:17 pm IST - NEW DELHI

A view of the World Health Organisation headquarters.

In a move meant to put the Indian system of medicine on the world map and provide it with a common standardised language, the Union government has sought for Ayurveda and related systems to be included in the 11th revision of the World Health Organisation’s International Classification of Diseases (ICD), as the second module of a supplementary chapter on traditional medicine conditions.

The ICD provides a common language that allows health professionals to share standardised information across the world. The traditional medicine module of the 11th revision provides a list of diagnostics categories to collect and report on traditional medicine conditions in a standardised and internationally comparable manner.

Speaking exclusively to The Hindu about the development, Ministry of Ayush Secretary Vaidya Rajesh Kotecha said: “We are hopeful that the addition of Module-2 for Ayurveda could happen as early as by next January.”

To aid regulation, research

“Ayurveda and related Indian traditional health care systems are formally recognised and widely practised health care systems in India, which is making a strong and valid point for its inclusion,” said Mr. Kotecha, adding that efforts to effectively regulate traditional medicine as an integral part of the health system require standardised and evidence-based information.

Mr. Kotecha further explained that the traditional medicine chapter under ICD-11 is a formative step for the integration of such forms of medicine into a classification standard used in conventional medicine. “It also provides the means for doing research and evaluation to establish its efficacy,” he said.

The Ministry added that this chapter would also help to respond to growing demands for more and better regulation of traditional medicine, and its integration in mainstream health care and health information systems.

ICD-11 covers Chinese medicine

After a decade of repeated consultations, ICD-11 had facilitated the inclusion of Module-1, which covers traditional medicine conditions originating in ancient China, which are now commonly used in China, Japan, Korea, and elsewhere around the world.

The eleventh revision contains around 17,000 unique codes and more than 1,20,000 codable terms, which are now entirely digital. ICD-11 came into effect from January 2022.

The joint use of ICD-11’s chapter on traditional medicine along with other chapters on neoplasm, patient safety, and injuries, can enhance the reporting of adverse events. It will enable the integration of traditional medicine into insurance coverage and reimbursement systems, in line with larger WHO objectives relating to universal health coverage. It will also link traditional medicine practices with global conventional medicine’s norms and standard development.

The development of Module-2 for Ayurveda-related diagnostic systems is being actively supported by the Ministry of Ayush. It extensively banks on the implementation experience gained on the ground by the National Ayush Morbidity and Standardised Terminologies Electronic portal, and the Ayush Health Information Management System, the Ministry said.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products

What is the traditional Indian medical system called?

The inclusion of Ayurveda in ICD-11 will provide a common language for health professionals to share standardized information across the world.